Iron excess treatable by copper supplementation in acquired aceruloplasminemia: A new form of secondary human iron overload?

Blood

Volumn 114, Issue 11, 2009, Pages 2360-2361

  Videt Gibou, Dorothée ^a   Belliard, Serge ^a   Bardou Jacquet, Edouard ^a   Troadec, Marie Bérengère ^a   Le Lan, Caroline ^a   Jouanolle, Anne Marie ^a   Loréal, Olivier ^a   Rivalan, Joseph ^a   Brissot, Pierre ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; CORTICOSTEROID; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ACERULOPLASMINEMIA; ADULT; ATAXIA; BONE DYSPLASIA; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; COPPER BLOOD LEVEL; COPPER DEFICIENCY; DYSERYTHROPOIESIS; ENZYME ACTIVITY; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MEGAKARYOCYTE; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; NEUTROPENIA; NEUTROPHIL COUNT; NORMOCHROMIC NORMOCYTIC ANEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEINURIA; SPINAL CORD; SPINE; SUPPLEMENTATION; TRANSFERRIN BLOOD LEVEL; URINARY EXCRETION; URINE LEVEL; BLOOD; DIET SUPPLEMENTATION; DIET THERAPY; DISORDERS OF METAL METABOLISM; MIDDLE AGED;

COPPER; DIETARY SUPPLEMENTS; HUMANS; IRON OVERLOAD; MALE; METAL METABOLISM, INBORN ERRORS; MIDDLE AGED;

EID: 70349569996     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-226175     Document Type: Letter

References (10)

1. Harris ZL, Klomp LW, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 1998;67:972S-977S.
2. De Domenico I, Ward DM, di Patti MC, et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007;26:2823-2831. (Pubitemid 46975784)
3. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 1987;37:761-767. (Pubitemid 17064662)
4. Loréal O, Turlin B, Pigeon C, et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol. 2002;36:851-856. (Pubitemid 35177417)
5. Gregg XT, Reddy V, Prchal JT. Copper deficiency masquerading as myelodysplastic syndrome. Blood. 2002;100:1493-1495. (Pubitemid 34864311)
6. Kumar N, Gross JB Jr, Ahlskog JE. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology. 2004;63:33-39. (Pubitemid 38943775)
7. Le Lan C, Ropert M, Lainé F, et al. Serum ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic cirrhosis: clinical and pathophysiological implications. Alcohol Clin Exp Res. 2004;28:775-779. (Pubitemid 38661375)
8. Nations SP, Boyer PJ, Love LA, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008;71:639-643.
9. Ulinski T, Aoun B, Toubiana J, Vitkevic R, Bensman A, Donadieu J. Neutropenia in congenital nephrotic syndrome of the Finnish type: role of urinary ceruloplasmin loss. Blood. 2009;113:4820-4821.
10. Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol. 2002;39:282-289.